Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,101,611
+$6,392,820 QoQ
Shares Held
61,776
+189.9% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 79.48717948717949.ToString("F0")%
Shared 20.51282051282051.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Derivatives in INSM
reported options exposure · as of Mar 31, 2026CallValue
$2,060,352
CallShares
12,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tidal Investments LLC holds $283,741,504 across 82 Biotechnology names. INSM ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
92,081 | $41,117,849 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
39,652 | $30,636,720 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,927 | $19,166,306 | |
| 4 | EXEL |
Exelixis, Inc.
|
382,343 | $16,398,690 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
137,242 | $13,346,784 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
167,598 | $10,831,857 | |
| 7 | INSM |
INSMED Inc
This page
|
61,776 | $10,101,611 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
129,601 | $9,624,170 |
All Filings in INSM
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,101,611 | 61,776 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $2,060,352 | 12,600 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $730,968 | 4,200 | Call | Defined | 2026-02-13 | |
| 2025-12-31 | $3,708,791 | 21,310 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,555,019 | 10,798 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $406,082 | 4,035 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $217,121 | 2,846 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $1,759,446 | 24,102 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $295,202 | 4,406 | Shares | Sole | 2024-08-14 | |
| 2022-03-31 | $803,559 | 34,194 | Shares | Sole | 2022-05-20 | |
| No filing history on record for this holder in this stock. | ||||||